Literature DB >> 12975003

[Association between AvaII exon 13 polymorphism at the LDL receptor gene different and serum lipid levels in normotensives and essential hypertensives in Shanghai].

Ai-ping Liu1, Si-yan Zhan, Li-ming Li, Yong-hua Hu, Wei-hua Cao, Tao Wu, Jun Li, Xiao-xia Guo.   

Abstract

OBJECTIVE: To investigate the AvaII polymorphism of low density lipoprotein receptor gene in both health and essential hypertension populations, and to evaluate the association of AvaII polymorphism with level of blood lipid.
METHODS: Using polymerase chain reaction (PCR), AvaII polymorphism was studied in 109 health individuals and 319 patients with essential hypertension.
RESULTS: There were three kinds of genotype: (+/+), (+/-), (-/-). The frequencies of the three genotypes were shown as follows: (+/+) 0.9%, (+/-) 27.5%, (-/-) 71.6% in health population and (+/+) 1.2%, (+/-) 33.9%, (-/-) 64.9% in essential hypertension population, respectively. The frequencies of the two alleles were shown as follows: (+) 14.7%, (-) 85.3% in health population, (+) 18.2%, (-) 81.8% in essential hypertension population and (+) 17.3%, (-) 82.7% in the community, respectively. In male essential hypertension cases, the genotypes were associated with serum TC and LDL-C level in the following order: (-/-) < (+/-) (P < 0.05). In women and healthy population, there was a similar trend but not statistically significant (P > 0.05).
CONCLUSIONS: A significant association was found between the common variation of LDL-R gene and serum TC and LDL-C levels. (+) Allele was associated with elevated level of serum TC and LDL-C, but (-) allele was associated with a low level of serum TC and LDL-C. The frequencies of (-) allele in both group were related to serum low level TC while LDL-C was much higher than that reported in the western countries. These data indicated that genetic factors which resistant to hypercholesterolemia in Chinese people were different from those findings in West while might be one of the reasons to explain why that serum TC level in Chinese was lower than people in the western countries.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12975003

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  6 in total

1.  APOE, MTHFR, LDLR and ACE polymorphisms among Angami and Lotha Naga populations of Nagaland, India.

Authors:  Benrithung Murry; Neikethono Vakha; Nongthombam Achoubi; M P Sachdeva; K N Saraswathy
Journal:  J Community Health       Date:  2011-12

2.  Exploration of the relationship between phlegm-dampness constitution and polymorphism of low density lipoprotein receptor genes Pvu II and Ava II.

Authors:  Jing Zhou; Hai-ming Luo
Journal:  Chin J Integr Med       Date:  2007-09       Impact factor: 1.978

3.  Interactions of several lipid-related gene polymorphisms and cigarette smoking on blood pressure levels.

Authors:  Rui-Xing Yin; Dong-Feng Wu; Jin-Zhen Wu; Xiao-Li Cao; Lynn Htet Htet Aung; Lin Miao; Xing-Jiang Long; Wan-Ying Liu; Lin Zhang; Meng Li
Journal:  Int J Biol Sci       Date:  2012-05-10       Impact factor: 6.580

4.  APOE polymorphisms contribute to reduced atorvastatin response in Chilean Amerindian subjects.

Authors:  Jenny Lagos; Tomás Zambrano; Alexy Rosales; Luis A Salazar
Journal:  Int J Mol Sci       Date:  2015-04-09       Impact factor: 5.923

5.  Association of polymorphisms of genes involved in lipid metabolism with blood pressure and lipid values in mexican hypertensive individuals.

Authors:  Blanca Estela Ríos-González; Bertha Ibarra-Cortés; Guadalupe Ramírez-López; José Sánchez-Corona; María Teresa Magaña-Torres
Journal:  Dis Markers       Date:  2014-12-21       Impact factor: 3.434

6.  Several lipid-related gene polymorphisms interact with overweight/obesity to modulate blood pressure levels.

Authors:  Rui-Xing Yin; Dong-Feng Wu; Lynn Htet Htet Aung; Ting-Ting Yan; Xiao-Li Cao; Xing-Jiang Long; Lin Miao; Wan-Ying Liu; Lin Zhang; Meng Li
Journal:  Int J Mol Sci       Date:  2012-09-24       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.